GCM
GMED icon

Geneva Capital Management’s Globus Medical GMED Stock Holding History

Geneva Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112M Sell
1,417,067
-343,904
-20% -$29.2M 2.57% 9
2026
Q1 		$152M Sell
1,760,971
-141,003
-7% -$12.7M 3.22% 4
2025
Q4 		$166M Sell
1,901,974
-181,965
-9% -$13.8M 3.12% 4
2025
Q3 		$119M Buy
2,083,939
+1,151
+0.1% +$66.3K 2.05% 14
2025
Q2 		$123M Buy
2,082,788
+249,141
+14% +$16.1M 2.06% 15
2025
Q1 		$134M Buy
1,833,647
+17,810
+1% +$1.47M 2.51% 10
2024
Q4 		$150M Buy
1,815,837
+217,707
+14% +$17.2M 2.61% 9
2024
Q3 		$114M Buy
1,598,130
+18,117
+1% +$1.28M 1.91% 13
2024
Q2 		$108M Buy
1,580,013
+8,127
+0.5% +$486K 1.97% 14
2024
Q1 		$84.3M Buy
1,571,886
+149,987
+11% +$8.06M 1.48% 22
2023
Q4 		$75.8M Sell
1,421,899
-325
-0% -$15.8K 1.43% 26
2023
Q3 		$70.6M Sell
1,422,224
-15,527
-1% -$868K 1.49% 26
2023
Q2 		$85.6M Buy
1,437,751
+4,013
+0.3% +$229K 1.69% 19
2023
Q1 		$81.2M Buy
1,433,738
+9,412
+0.7% +$604K 1.65% 17
2022
Q4 		$106M Buy
1,424,326
+18,555
+1% +$1.26M 2.38% 6
2022
Q3 		$83.7M Buy
1,405,771
+53,773
+4% +$3.24M 1.93% 11
2022
Q2 		$75.9M Buy
1,351,998
+142,013
+12% +$9.33M 1.75% 13
2022
Q1 		$89.3M Sell
1,209,985
-12,074
-1% -$839K 1.72% 12
2021
Q4 		$88.2M Sell
1,222,059
-26,015
-2% -$1.89M 1.42% 20
2021
Q3 		$95.6M Sell
1,248,074
-8,452
-0.7% -$679K 1.62% 15
2021
Q2 		$97.4M Sell
1,256,526
-20,922
-2% -$1.49M 1.59% 15
2021
Q1 		$78.8M Buy
1,277,448
+322,334
+34% +$20.4M 1.34% 24
2020
Q4 		$62.3M Buy
955,114
+26,034
+3% +$1.5M 1.06% 36
2020
Q3 		$46M Buy
929,080
+22,562
+2% +$1.16M 0.95% 45
2020
Q2 		$43.3M Buy
906,518
+24,876
+3% +$1.2M 0.94% 44
2020
Q1 		$37.5M Buy
+881,642
New +$43.6M 1.07% 37

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geneva Capital Management's GMED Position: Q2 2026 in Review

Geneva Capital Management reduced its Globus Medical (GMED) stake by 20% in Q2 2026, selling an estimated $29.2M and leaving 1,417,067 shares worth $112M. The position accounts for 2.57% of the portfolio, ranked #9.

Geneva Capital Management first reported a position in GMED in Q1 2020 and has held it in 26 quarters since. The position peaked at $166M in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Geneva Capital Management held 1,417,067 shares of Globus Medical worth $112M as of Q2 2026.
  • Geneva Capital Management sold 343,904 Globus Medical shares in Q2 2026, an estimated $29.2M.
  • Globus Medical made up 2.57% of Geneva Capital Management's portfolio in Q2 2026, its #9 holding.
  • Geneva Capital Management first reported a position in Globus Medical in Q1 2020 and has held it in 26 quarters since.
  • Geneva Capital Management's Globus Medical position peaked at $166M in Q4 2025.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.